Award recordCONTRACT

MYLAN PHARMACEUTICALS INC

PIID 36E79719N0004· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $45,433 net obligations· UEI NDN1MYB8DKK5· WV

Description

DEOBLIGATE FUNDS ON THE TASK ORDER FOR SPIRONOLACTONE TABLETS FOR THE PHARM REPACKAGING PROGRAM. THE ORDER SHORT SHIPPED BY 1 BOTTLE

Base award description: TASK ORDER FOR SPIRONOLACTONE TABLETS FOR THE PHARM REPACKAGING PROGRAM.

First action · last action
2018-11-06 · 2019-09-16
Transactions
2
First transaction's obligation
$45,446
Base + all options value (sum of deltas)
$45,433
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0009
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$45,446$0Base award · 2018-11-06 · this action $45,446 · running total $45,446Modification P00001 · 2019-09-16 · this action -$13 · running total $45,433
  • Base2018-11-06+$45,446= $45,446
  • Mod P000012019-09-16-$13= $45,433
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-11-06+$45,446$45,446TASK ORDER FOR SPIRONOLACTONE TABLETS FOR THE PHARM REPACKAGING PROGRAM.
Mod P00001· FUNDING ONLY ACTION2019-09-16−$13$45,433DEOBLIGATE FUNDS ON THE TASK ORDER FOR SPIRONOLACTONE TABLETS FOR THE PHARM REPACKAGING PROGRAM. THE ORDER SHO…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NDN1MYB8DKK5)

AwardOffice · PSC / listingNet obligationsFY
36E79726D0033NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79725D0054NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79723D0015NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36F79723D0025NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79722D0014NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36E79721N0050NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36E79719N0004_3600_VA797P15A0009_3600 · retrieved 2026-09-26.